On ECHEMI
Home > Drugs > Suzhou Pharmaceutical Factory
Suzhou Pharmaceutical Factory
  • Founded in:

    2006-02-14
  • Country:

    China China
  • Address:

    No. 2-1, Dongwu South Road, Wuzhong District, Suzhou City
  • Tax NO.:

    91320506138170408U
  • Registered Funds:

    -
  • Website:

  • Email:

Related Drugs
Ribavirin
Ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

Extract from the above information

More

Extract from the above information

36791-04-5 33
Adenosine triphosphate disodium for injection
Chemical name: adenosine-5-triphosphate disodium salt, molecular formula: C10H14N5Na2O13P3 molecular weight: 551.15
Name Description Content CAS NO. Registered Holders
Adenosine5'-(tetrahydrogen triphosphate), disodiuM salt, trihydrate (9CI)

It is a coenzyme that improves the body's metabolism and participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. It is also the main source of energy in the body. When energy is needed for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Animal experiments can inhibit the slow calcium ion influx of slow-reacting fibers, block or delay the forward conduction in the atrioventricular node reentry pathway, and large doses may also block or delay the forward and reverse conduction of the bypass pathway; in addition, it also has a short-term and strong effect of enhancing the vagus nerve, thereby terminating arrhythmias caused by atrioventricular node reentry and bypass reentry mechanisms.

More

It is a coenzyme that improves the body's metabolism and participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. It is also the main source of energy in the body. When energy is needed for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Animal experiments can inhibit the slow calcium ion influx of slow-reacting fibers, block or delay the forward conduction in the atrioventricular node reentry pathway, and large doses may also block or delay the forward and reverse conduction of the bypass pathway; in addition, it also has a short-term and strong effect of enhancing the vagus nerve, thereby terminating arrhythmias caused by atrioventricular node reentry and bypass reentry mechanisms.

51963-61-2 0
Vitamin D2 Calcium Fructose Injection
This product is a sterilized white translucent emulsion of vitamin D2 and organic calcium agent. The calcium (Ca) content should be 95.0%-105.0% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Vitamin D2

It must be converted by both the liver and kidneys to become biologically active vitamin D3, which plays a role in regulating calcium and phosphorus metabolism. The biological activity of vitamin D2 is far inferior to that of vitamin D3.

More

It must be converted by both the liver and kidneys to become biologically active vitamin D3, which plays a role in regulating calcium and phosphorus metabolism. The biological activity of vitamin D2 is far inferior to that of vitamin D3.

50-14-6 14
Organic calcium supplement

Participates in the regulation of calcium and phosphorus metabolism.

More

Participates in the regulation of calcium and phosphorus metabolism.

95.0%-105.0%Label quantity 0
Calcium Fructose
Name Description Content CAS NO. Registered Holders
CALCIUM LEVULINATE

Not clearly described

More

Not clearly described

591-64-0 2
Fluorouracil Injection
The chemical name of this product is: 5-fluoro-2,4(1H,3H)-pyrimidinedione.
Name Description Content CAS NO. Registered Holders
5-Fluorouracil

This product is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, by preventing uracil and orotic acid from incorporating into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle-specific drug that mainly inhibits S-phase cells.

More

This product is first converted into 5-fluoro-2-deoxyuridine nucleotide in the body, which inhibits thymine nucleotide synthetase, blocking the conversion of deoxyuridine nucleotide into deoxythymine nucleotide, thereby inhibiting DNA biosynthesis. In addition, by preventing uracil and orotic acid from incorporating into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle-specific drug that mainly inhibits S-phase cells.

51-21-8 21
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.